Azome Therapeutics is an early-stage drug discovery company focused on developing selective antagonists of the NLRP3 inflammasome, an inflammatory pathway critical to the development of a wide variety of diseases.
Our lead candidate, AZM-152, is a RHAMM-derived antagonist that blocks a key upstream priming signal involved in the aberrant activation of the NLRP3 inflammatory cascade.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://azometherapeutics.com
Azome Therapeutics Questions
Azome Therapeutics's website is https://azometherapeutics.com
Azome Therapeutics's LinkedIn profile is https://www.linkedin.com/company/azome-therapeutics
Azome Therapeutics has
2 employees.
View email and phone details for 2
employees at Azome Therapeutics.
Azome Therapeutics's industry is
Biotechnology Research
Azome Therapeutics's top competitors are
Imaginostics,
Kaida Biopharma,
Meco Diagnostics,
Amend Surgical, Inc.,
3daughters,
Annovis Bio, Inc.,
Vanquish Bio,
Ziptek Llc,
Osteocure Therapeutics,
Eder Therapeutics.
Azome Therapeutics's categories are Biotechnology Research
Azome Therapeutics's founding year is 2023
